ATEC(Alphatec Holdings, Inc.) · 财务报表

ATEC(Alphatec Holdings, Inc.) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$243.21M$350.87M$482.26M$611.56M$764.15M
毛利润$157.76M$233.06M$310.20M$424.26M$531.89M
营业利润−$128.06M−$146.97M−$173.40M−$136.17M−$82.13M
净利润−$143.03M−$151.29M−$186.64M−$162.12M−$143.36M
经营现金流−$73.32M−$75.13M−$78.48M−$44.65M$45.23M
自由现金流−$141.86M−$124.59M−$158.99M−$127.87M$2.78M
摊薄每股收益$-1.49$-1.46$-1.54$-1.13$-0.96

Alphatec Holdings, Inc. ATEC